Imprivata net profit rises 45% in first half of 2012
Imprivata has said it has reported 45% growth in first half of 2012 year-on-year worldwide. The company added 105 new healthcare customers in the first six months of 2012. This has led to getting the support for the company’s number 1 Single Sign-On (SSO) market share leadership position in the U.S. acute care hospitals since the beginning of 2012.
The new customers added include South Eastern Health & Social Care Trust of Northern Ireland, The Mid Yorkshire Hospitals NHS Trust, University of Texas MD Anderson Cancer Center, Blue Care in Australia, The Nermours Foundation, and the University of California-Irvine Medical Center and Klinikum-Wels in Austria.
Imprivata has recently made investments in mainland Europe and Australia, which has resulted in addition of 15 new customers in the first half of 2012. Imprivata OneSign is also playing a larger role in speeding Electronic Health Records adoption, a vital component for facilities to meet meaningful use deadlines.
Its health partnership announced in February has resulted in 15 new hospitals implementing Imprivata OneSign-10 of which are competitive replacements.
The revenue coming through Forward Advantage, Siemens, and Cerner and other partners continued to increase in the first half of 2012, the company said. Other milestones during the first half of 2012 include the new products and partnerships, notable industry recognition, and organizational developments.
The company has seen 20% employee growth and targets an additional 25% growth by year-end. It introduced Cortext, a free HIPAA compliant text messaging solution. It also expanded its business overseas in countries including France, Germany and Australia.
The new hires added include Mark Clark, Vice President of International Sales based in UK and John Milton, Vice President and General Counsel based in Lexington Mass.
Omar Hussain, Imprivata President and CEO said, “Automation is the key to resolving the healthcare crisis.” He also said, “Our growth parallels the digital revolution in healthcare as we continue to enable providers to securely access and collaborate around electronic health information regardless of location or device being used. We clearly see our market share continuing to strengthen, particularly as data becomes more portable and users become more mobile.”
Imprivata is also hosting the First Annual Imprivata HealthCon 2012 User Conference, November 6-8 at the Hyatt Regency in Boston. The 2-day event will feature over 30 sessions hosted by Imprivata product experts and customers.
Imprivata provides secure access solutions for healthcare, government, finance and other regulated industries. It has also secured many product awards and top review ratings from well-known industry publications and analysts. The group has also partnered with more than 200 resellers and serves the secure access and collaboration needs of the customers around the world.
Dexcom: changing the lives of people with type 1 diabetes
It is estimated that 9.3% of adults around the world are living with type 1 diabetes, which amounts to a total of 463 million people. A further 1.1 million children and adolescents under the age of 20 are living with the condition.
Unlike the more prevalent type 2 diabetes, where the body still produces insulin and symptoms develop slowly, people with type 1 diabetes need regular insulin injections or pumps, and must monitor their sugar levels frequently.
In recent years a number of remote glucose monitoring systems have become available that patients can use at home. These work with a sensor, usually placed under the skin, that measures glucose levels every few minutes. This information is then transmitted wirelessly to a device like a smartphone or tablet, which can then be shared with their clinician.
British actress Nina Wadia's son Aidan, 14, has type 1 diabetes, and has been managing his condition using Dexcom, a glucose monitoring system used by patients all over the world. Here Wadia explains how Dexcom has improved their lives.
As a parent of someone with type 1 diabetes, what is your day-to-day life like?
Being able to take a breath, think and pivot constantly without getting frustrated becomes an essential mindset because sometimes it feels like each day is determined to be different from the day before. Whatever worked yesterday is going to misfire today.
Which areas of yours and Aidan’s life are most impacted by diabetes?
The one thing that you have to fight hard to reclaim is spontaneity, especially when it comes to food and exercise. It’s only when this is taken do you realise how essential each one is. You can be flexible and there are no real limits, but only in the sense that a great athlete can be flexible without limits because they’ve trained super hard to be that way. So we’ve all had to become athletes when it comes to being spontaneous.
How has Dexcom helped you and Aidan?
Dexcom has brought future science fiction to real life today. The continuous glucose monitoring system is tiny, sits discreetly on his body and gives him a ten-day breather between sensor changes, so it's goodbye finger-pricking seven times daily.
Dexcom is totally active at a grass roots level and for Diabetes Awareness has pledged to donate £2,000 if #DexcomDiabetesStories and/or #DexcomWarriorStories is shared 200 times! I’ll be sharing more on social media and would love to hear how other families are winning their fights.
Maybe most importantly Dexcom is trying to introduce a reimbursement programme for type 1 diabetes patients which will give greater access to modern, life changing hi-tech. I want to spread the word on the importance of accessing it through this campaign.
If you compared your life today with how it was before Aidan was using Dexcom, what has changed?
It's always working, which lets him take his mind off diabetes for longer stretches. It also lets me get off his back. We both receive alerts so I no longer have to pester him by asking him what his number is, and especially importantly, I don’t have to wake him at night to prick his finger if I’m worried. Dexcom gave us back our sleep!